Previous 10 | Next 10 |
Announced Path Forward for VS-6766 and Defactinib Combination Following Meeting with FDA Phase 2 Registration-Directed Trials Expected to Commence by Year End 2020 in Both Low-Grade Serous Ovarian Cancer and KRAS Mutant Non-Small Cell Lung Cancer Company Monetizes COPIKTRA ® ...
Verastem Will Receive $70 Million Up-Front with Total Deal Value Up to $311 Million, Plus Double-Digit Sales Royalties Upon Closing, Verastem’s Current Programs Will Be Funded Until At Least 2024 to Develop VS-6766 and Defactinib in Low-Grade Serous Ovarian Cancer and KRAS Muta...
SilverSun Technologies (NASDAQ: SSNT ) +386% on acquiring Prairie Technology Solutions. More news on: SilverSun Technologies, Inc., Alterity Therapeutics Limited, Zhongchao Inc., Stocks on the move, , Read more ...
Editor's note: Seeking Alpha is proud to welcome Mihai Michel as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more » With its stock price...
Data Presented at the American Association for Cancer Research 2020 Virtual Annual Meeting II Show Synergism between FAK and RAF/MEK Inhibition Supporting Clinical Evaluation of Defactinib with VS-6766 in Metastatic Uveal Melanoma Verastem’s RAF/MEK Inhibitor (VS-6766) and FAK I...
Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to developing and commercializing new medicines for patients battling cancer, today announced that the Company will present at the Jefferies Virtual Healthcare Conference on Thursday, June 4,...
Weekend Penny Stocks To Watch Before Monday I know it’s the weekend but money doesn’t sleep; it just takes a breather on Saturday and Sunday. That also goes for penny stocks . But that doesn’t mean you can’t take these days to do some research and prepare for the w...
Are These On Your List Of Penny Stocks In May? Penny stocks are a different breed of equities. If you’re used to buying and holding large-cap stocks, you might have to shift your thinking a bit when it comes to small-cap stocks. But just because these cheap shares move up and down qui...
Verastem (NASDAQ: VSTM ): Q1 GAAP EPS of -$0.35 misses by $0.14 . More news on: Verastem, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Company to Pursue Low-Grade Serous Ovarian Cancer Indication for VS-6766 with Defactinib; On Track to Initiate Discussions with FDA Company Reports $5.0M in Net Product Revenue; With Newly Strengthened Balance Sheet, Company is Well Positioned to Execute on Key Corporate Objectives in...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten public offering of 13,333,334 shares of its common stock and accompanying warrants to purchase up to 13,333,334 shares of it...
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of common stock, as well as pre-funded warrants t...